ES2334497T3 - Biomateriales basados en ester bencilico de acido hialuronico para terapia anti-angiogenica en el tratamiento de tumores. - Google Patents

Biomateriales basados en ester bencilico de acido hialuronico para terapia anti-angiogenica en el tratamiento de tumores. Download PDF

Info

Publication number
ES2334497T3
ES2334497T3 ES03700315T ES03700315T ES2334497T3 ES 2334497 T3 ES2334497 T3 ES 2334497T3 ES 03700315 T ES03700315 T ES 03700315T ES 03700315 T ES03700315 T ES 03700315T ES 2334497 T3 ES2334497 T3 ES 2334497T3
Authority
ES
Spain
Prior art keywords
use according
synthetic
biomaterial
angiogenic
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES03700315T
Other languages
English (en)
Spanish (es)
Inventor
Norbert E. Fusenig
Hans-Jurgen Stark
Michael Willhauck
Alessandra Pavesio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deutsches Krebsforschungszentrum DKFZ
Fidia Farmaceutici SpA
Original Assignee
Deutsches Krebsforschungszentrum DKFZ
Fidia Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforschungszentrum DKFZ, Fidia Farmaceutici SpA filed Critical Deutsches Krebsforschungszentrum DKFZ
Application granted granted Critical
Publication of ES2334497T3 publication Critical patent/ES2334497T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES03700315T 2002-01-11 2003-01-07 Biomateriales basados en ester bencilico de acido hialuronico para terapia anti-angiogenica en el tratamiento de tumores. Expired - Lifetime ES2334497T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITPD02A0003 2002-01-11
IT2002PD000003A ITPD20020003A1 (it) 2002-01-11 2002-01-11 Biomateriali a base di acido ialuronico come terapia anti-angiogenicanella cura dei tumori.

Publications (1)

Publication Number Publication Date
ES2334497T3 true ES2334497T3 (es) 2010-03-11

Family

ID=11452500

Family Applications (1)

Application Number Title Priority Date Filing Date
ES03700315T Expired - Lifetime ES2334497T3 (es) 2002-01-11 2003-01-07 Biomateriales basados en ester bencilico de acido hialuronico para terapia anti-angiogenica en el tratamiento de tumores.

Country Status (12)

Country Link
US (1) US7838510B2 (enExample)
EP (1) EP1463541B1 (enExample)
JP (1) JP4603263B2 (enExample)
AT (1) ATE448809T1 (enExample)
AU (1) AU2003201618B2 (enExample)
CA (1) CA2472880C (enExample)
DE (1) DE60330113D1 (enExample)
DK (1) DK1463541T3 (enExample)
ES (1) ES2334497T3 (enExample)
IT (1) ITPD20020003A1 (enExample)
PT (1) PT1463541E (enExample)
WO (1) WO2003057203A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITPD20040312A1 (it) * 2004-12-15 2005-03-15 Fidia Advanced Biopolymers Srl Protesi e o supporto per la sostituzione, riparazione, rigenerazione del menisco

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6117A (ja) * 1984-06-11 1986-01-06 Seikagaku Kogyo Co Ltd ムコ多糖系癌転移抑制剤
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5143724A (en) 1990-07-09 1992-09-01 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
IT1254704B (it) * 1991-12-18 1995-10-09 Mini Ricerca Scient Tecnolog Tessuto non tessuto essenzialmente costituito da derivati dell'acido ialuronico
CA2094203A1 (en) * 1993-04-16 1994-10-17 Derek A. Willoughby Inhibition of angiogenesis
ITPD940054A1 (it) * 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
IL123500A (en) * 1995-08-29 2003-06-24 Fidia Advanced Biopolymers Srl Composite biomaterials for preventing post-surgical adhesions of tissues
US6579978B1 (en) * 1997-04-04 2003-06-17 Fidia Farmaceuti S.P.A. Biomaterials comprising N-sulphated hyaluronic acid compounds or derivatives thereof
IT1293484B1 (it) * 1997-06-11 1999-03-01 Fidia Advanced Biopolymers Srl Materiale biologico comprendente una efficiente coltura di cellule e una matrice tridimensionale biocompatibile e biodegradabile
US6872819B1 (en) * 1998-05-27 2005-03-29 Fidia Advanced Biopolymers S.R.L. Biomaterials containing hyaluronic acid derivatives in the form of three-dimensional structures free from cellular components or products thereof for the in vivo regeneration of tissue cells
ITPD980169A1 (it) 1998-07-06 2000-01-06 Fidia Advanced Biopolymers Srl Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
WO2000054762A2 (en) * 1999-03-15 2000-09-21 Trustees Of Boston University Use of cross linked polysaccharides for the inhibition of angiogenesis
CA2366604A1 (en) 1999-03-26 2000-10-05 The University Of Texas System Modulators of polysaccharides and uses thereof
IT1317359B1 (it) * 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e
IT1317358B1 (it) * 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Derivati cross-linkati dell'acido ialuronico.
WO2002041877A1 (en) * 2000-10-24 2002-05-30 Clear Solutions Biotech, Inc. Sodium hyaluronate microspheres

Also Published As

Publication number Publication date
US7838510B2 (en) 2010-11-23
ATE448809T1 (de) 2009-12-15
EP1463541B1 (en) 2009-11-18
ITPD20020003A1 (it) 2003-07-11
US20050037049A1 (en) 2005-02-17
CA2472880A1 (en) 2003-07-17
DK1463541T3 (da) 2010-03-08
AU2003201618B2 (en) 2008-11-06
WO2003057203A3 (en) 2003-12-31
DE60330113D1 (de) 2009-12-31
WO2003057203A2 (en) 2003-07-17
JP4603263B2 (ja) 2010-12-22
EP1463541A2 (en) 2004-10-06
JP2005524619A (ja) 2005-08-18
CA2472880C (en) 2011-08-16
AU2003201618A1 (en) 2003-07-24
PT1463541E (pt) 2010-01-07

Similar Documents

Publication Publication Date Title
Yang et al. Designer self‐assembling peptide hydrogels to engineer 3D cell microenvironments for cell constructs formation and precise oncology remodeling in ovarian cancer
Nelson et al. Preferential, enhanced breast cancer cell migration on biomimetic electrospun nanofiber ‘cell highways’
Wang et al. MXenes-integrated microneedle combined with asiaticoside to penetrate the cuticle for treatment of diabetic foot ulcer
ES3002759T3 (en) Controllable self-annealing microgel particles for biomedical applications
Kievit et al. Chitosan–alginate 3D scaffolds as a mimic of the glioma tumor microenvironment
US11413329B2 (en) Cancer cell trap
Kim et al. Three-dimensional gastric cancer cell culture using nanofiber scaffold for chemosensitivity test
Coulter et al. Enzyme‐triggered l‐α/d‐peptide hydrogels as a long‐acting injectable platform for systemic delivery of HIV/AIDS drugs
Vedaraman et al. Bicyclic RGD peptides enhance nerve growth in synthetic PEG-based Anisogels
Goncalves et al. Key participants of the tumor microenvironment of the prostate: An approach of the structural dynamic of cellular elements and extracellular matrix components during epithelial–stromal transition
Huang et al. Mimicking the endometrial cancer tumor microenvironment to reprogram tumor-associated macrophages in disintegrable supramolecular gelatin hydrogel
Said et al. Controlled delivery of fibroblast growth factor-9 from biodegradable poly (ester amide) fibers for building functional neovasculature
Xu et al. Functional hydrogels for hepatocellular carcinoma: therapy, imaging, and in vitro model
Han et al. Injectable bio-multifunctional hyaluronic acid-based hydrogels loaded with poly ADP-ribose polymerase inhibitors for ovarian cancer therapy
Zhu et al. Potential effects of biomaterials on macrophage function and their signalling pathways
ES2334497T3 (es) Biomateriales basados en ester bencilico de acido hialuronico para terapia anti-angiogenica en el tratamiento de tumores.
Lu et al. Lanthanum-doped chitosan hydrogels promote the apoptosis of melanoma cells by Bcl-2/Bax pathway
RU2723215C2 (ru) Способ лечения заболевания с использованием соединения, оказывающего воздействие на гликолиз
Harmon et al. Effects of fibrin pad hemostat on the wound healing process in vivo and in vitro
Verhoeven et al. Proliferation, basement membrane changes, metastasis and vascularization patterns in human breast cancer
Morris III et al. Postoperative Adhesions: Current Research on Mechanisms, Therapeutics and Preventative Measures
Zheng et al. Nature-skin-based multi-responsive controlled-release electroactive scaffolds for integrated melanoma postoperative relapse prevention and wound therapy
Amorim et al. Biomatrices that mimic the cancer extracellular environment
US20220054527A1 (en) Method of treating a disease using a glycolytic dependent compound
Kwakwa Targeting Gli-Mediated Transcription in Bone Metastasis: An Emerging Therapeutic Approach for Patients with Tumor-Induced Bone Disease